Skip to content
The US Food and Drug Administration (FDA) is “close to authorizing updated doses that would target the versions of the virus now circulating,” Dr. […]
Biden administration to offer updated jabs in fall booster campaign Read More »
The U.S. Food and Drug Administration (FDA) has received Moderna’s application for emergency use authorization for its bivalent booster vaccine, mRNA-1273.222, which targets the
Moderna’s bivalent booster awaits emergency use authorization Read More »
In an opinion piece for Agri-Pulse, Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Health argued that “FDA’s recent efforts to develop a
BIO CEO: Regulatory certainty needed to encourage food innovation Read More »
Updated efficacy data from a Phase 2/3 trial testing three 3-g doses of the Pfizer-BioNTech COVID-19 vaccine in children aged 6 months to 4
Pfizer: COVID-19 vaccine effective in children 6 months to 4 years Read More »
“1,000-year” rainfalls, which can cause greater harm when they hit drought-stricken areas, are aggravating record heat and water shortages across the United States, according
World Water Week: What’s the role for biotech in restoring water balance? Read More »
Biotech partners Pfizer and BioNTech announced on Monday that they have requested Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)
Pfizer-BioNTech requests federal authorization for Omicron-adapted booster Read More »
Despite the advancement of prevention, detection, and early treatment options for many cervical cancers, late-stage cervical cancer diagnoses are up in the United States,
Late-stage cervical cancer on the rise despite jab, early treatment options Read More »
Drought continues to dominate headlines worldwide—and it’s having an acute impact on farmers in the U.S, Good Day BIO reports. According to the Biotechnology
Biotech can help reduce the impact of drought on America’s farmers Read More »
The European Commission (EC) has granted Marketing Authorization for the first twice-yearly HIV therapy, Sunlenca (lenacapavir), developed by Gilead Sciences, the biopharmaceutical company announced
Sunlenca, the first twice-yearly HIV therapy, approved by European Commission Read More »
The U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Novavax COVID-19 vaccine Adjuvanted (NVX-CoV2373) “for the prevention of Coronavirus Disease
Novavax COVID vaccine granted EUA for adolescents ages 12 to 17 Read More »
